As of 2025-11-18, the Fair Value of Molecular Partners AG (MOLN.SW) is -21.01 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.38 CHF, the upside of Molecular Partners AG is -721.51%.
With the market price of 3.38 CHF and our fair value calculation, Molecular Partners AG (MOLN.SW) is not a good investment. Investing in MOLN.SW stocks now will result in a potential loss of 721.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -62.76 | -63.78 | 117.85 | -61.98 | -54.04 | -24.94 |
| YoY growth | -72.96% | -1.63% | 284.77% | -152.59% | 12.81% | 14.08% |
| Market Cap (mil) | 136.45 |
| P/E | |
| Forward P/E |
| EPS | -1.49 |
| Avg earnings growth rate | 14.08% |
| TTM earnings | -60.24 |